ARK Invest CEO Cathie Wood expressed reservations about participating in the initial public offering (IPO) of British chip designer Arm, citing overvaluation relative to its competitive...
By Shristi Achar A and Amruta Khandekar (Reuters) - The S&P 500 and Nasdaq fell on Thursday with Apple (NASDAQ:AAPL) leading declines in megacap growth stocks on concerns over China's...
An analyst from Macquarie maintained UiPath (NYSE: PATH) at 'outperform' with a price target of $23.00 from a prior price target of $22.00. Prior to this rating, UiPath had 8 buy ratings,...
An analyst from Canaccord Genuity maintained UiPath (NYSE: PATH) at 'buy' with a price target of $21.00 from a prior price target of $19.00. Prior to this rating, UiPath had 8 buy ratings,...
An analyst from Mizuho Securities maintained UiPath (NYSE: PATH) at 'neutral' with a price target of $18.00 from a prior price target of $16.00. Prior to this rating, UiPath had 8 buy...
An analyst from BMO Capital maintained UiPath (NYSE: PATH) at 'market perform' with a price target of $19.00 from a prior price target of $18.00. Prior to this rating, UiPath had 8 buy...
An analyst from RBC Capital maintained UiPath (NYSE: PATH) at 'sector perform' with a price target of $19.00 from a prior price target of $18.00. Prior to this rating, UiPath had 8 buy...
An analyst from Barclays maintained UiPath (NYSE: PATH) at 'equalweight' with a price target of $18.00 from a prior price target of $16.00. Prior to this rating, UiPath had 8 buy ratings,...
DA Davidson analyst raised the price target on UiPath Inc. (PATH) to $17.00 (from $16.00) while maintaining a Neutral rating.
ARK Invest CEO Cathie Wood recently expressed her belief in the transformative potential of the convergence between artificial intelligence (AI) and Bitcoin, predicting that this synergy...
After-Hours Stock Movers: Verint Systems (NASDAQ:VRNT) 14% LOWER; {{erl-39157||reported Q2 EPS of $0.48, $0.09 worse than the analyst estimate of $0.57. Revenue for the quarter came in...
Investing.com - UiPath (NYSE: PATH) reported third quarter EPS of $0.09, $0.05 better than the analyst estimate of $0.04. Revenue for the quarter came in at $287M versus the consensus...
Wells Fargo analysts downgraded UiPath Inc (NYSE:PATH) shares to Equal Weight from Overweight with the price target unchanged at $20 per share. The analysts made a move after seeing PATH...
By Davit KirakosyanHere is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at |Target, QuantumScape, UiPath, and First Northwest...
An analyst from Wells Fargo downgraded Uipath (NYSE: PATH) from 'overweight' to 'equal weight' with a price target of $20.00. Prior to this rating, Uipath had 9 buy ratings, 12 hold...
Investing.com -- Software providers will be the next businesses to benefit from a spike in interest in artificial technology that has spurred on rapid growth in Nvidia (NASDAQ:NVDA) shares,...
Investing.com -- The Dow ends lower after giving up gains Tuesday, as the rally in semiconductor stocks cooled and investors mulled over the prospect of Congress passing the debt ceiling...
Investing.com -- The S&P 500 gave up gains Tuesday, as investors mulled over the prospect of Congress passing the debt ceiling bill before the June 5 deadline to avoid a default. The...
UiPath (NYSE:PATH) shares fell 8.2% in pre-market Thursday after the automation software company offered a weaker-than-expected forecast for its second quarter. As far as Q1 results are...
An analyst from BMO Capital maintained Uipath (NYSE: PATH) at 'market perform' with a price target of $18.00 from a prior price target of $20.00. Prior to this rating, Uipath had 9 buy...
An analyst from Evercore ISI maintained Uipath (NYSE: PATH) at 'in line' with a price target of $18.00 from a prior price target of $20.00. Prior to this rating, Uipath had 9 buy...
An analyst from Barclays maintained Uipath (NYSE: PATH) at 'equalweight' with a price target of $16.00 from a prior price target of $17.00. Prior to this rating, Uipath had 9 buy...
Investing.com - Uipath (NYSE: PATH) reported second quarter EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $289.6M versus the consensus...
A DA Davidson analyst initiated new coverage Uipath (NYSE: PATH) Neutral rating and a price target of $16.00. Prior to this rating, Uipath had 9 buy ratings, 12 hold ratings, and 1 sell...
UiPath (PATH), a leading enterprise automation software company, today announced the appointment of Karenann Terrell to its Board of Directors. Terrell brings decades of experience in...
A Truist Securities analyst maintained Uipath (NYSE: PATH) at Buy and a price target of $No data. Prior to this rating, Uipath had 8 buy ratings, 12 hold ratings, and 0 sell ratings. For...
A TD Cowen analyst maintained Uipath (NYSE: PATH) at Outperform and a price target of $22.00 from a prior price target of $20.00. Prior to this rating, Uipath had 8 buy ratings, 12 hold...
By Sam Boughedda Morgan Stanley analysts told investors in a note Friday that UiPath Inc's (NYSE:PATH) AI Summit provided an early look at the strategy and productization of AI capabilities...
By Yasin Ebrahim Investing.com -- The Dow closed higher Thursday, as reports major Wall Street banks are lining up to rescue First Republic Bank brought calm to markets following days of...
By Oliver Gray Investing.com - U.S. stock futures were trading in a mixed fashion during Wednesday's evening trade amid growing fears of a widespread banking crisis as Credit Suisse...
By Davit Kirakosyan UiPath Inc (NYSE:PATH) shares jumped more than 12% after-hours following the company's reported {{erl-1172518||Q4 results, with EPS of $0.15 coming in better than the...
After-Hours Stock Movers: Esperion Therapeutics (NASDAQ:ESPR) 62% LOWER; reports Daiichi Sankyo disagrees with the company’s assessment that CLEAR Outcomes data would support milestone...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
